IDEAYA Biosciences, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
IDEAYA Biosciences, Inc. (IDYA) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$1.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-04
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$1.18M.
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$2.76M, a 457.18% decline year-over-year.
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $215.00K.
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $531.00K, a 89.89% decline year-over-year.
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $1.46M, a 482.00% increase from fiscal 2024.
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $250.00K, a 92.72% decline from fiscal 2023.
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $3.43M.
- IDEAYA Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$2.16M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.18M 10-Q · filed 2026-08-04 | -$3.94M 10-Q · filed 2026-08-04 | -$3.72M derived: sum of 3 quarters · filed 2026-08-04 | -$3.19M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$2.76M 10-Q · filed 2026-05-05 | -$2.55M derived: sum of 2 quarters · filed 2026-05-05 | -$2.02M derived: sum of 3 quarters · filed 2026-05-05 | -$2.08M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $746.00K derived: sum of 2 quarters · filed 2026-02-17 | $682.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.46M 10-K · filed 2026-02-17 |
| 2025-09-30 | $531.00K 10-Q · filed 2025-11-04 | $467.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.24M 10-Q · filed 2025-11-04 | -$1.78M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$64.00K 10-Q · filed 2026-08-04 | $709.00K 10-Q · filed 2026-08-04 | -$2.31M derived: sum of 3 quarters · filed 2026-08-04 | $2.94M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $773.00K 10-Q · filed 2026-05-05 | -$2.25M derived: sum of 2 quarters · filed 2026-05-05 | $3.00M derived: sum of 3 quarters · filed 2026-05-05 | $2.51M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.23M derived: sum of 2 quarters · filed 2026-02-17 | $1.74M derived: sum of 3 quarters · filed 2026-02-17 | $250.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $5.25M 10-Q · filed 2025-11-04 | $4.76M derived: sum of 2 quarters · filed 2025-11-04 | $3.27M 10-Q · filed 2025-11-04 | $4.59M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$493.00K 10-Q · filed 2025-08-05 | -$1.98M 10-Q · filed 2025-08-05 | -$666.00K derived: sum of 3 quarters · filed 2026-02-17 | -$237.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$1.49M 10-Q · filed 2025-05-06 | -$173.00K derived: sum of 2 quarters · filed 2026-02-17 | $256.00K derived: sum of 3 quarters · filed 2026-02-17 | $482.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.74M derived: sum of 2 quarters · filed 2026-02-17 | $1.97M derived: sum of 3 quarters · filed 2026-02-17 | $3.43M 10-K · filed 2026-02-17 |
| 2023-09-30 | $429.00K 10-Q · filed 2024-11-04 | $655.00K derived: sum of 2 quarters · filed 2024-11-04 | $2.12M 10-Q · filed 2024-11-04 | $3.25M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $226.00K 10-Q · filed 2024-08-06 | $1.69M 10-Q · filed 2024-08-06 | $2.82M derived: sum of 3 quarters · filed 2025-02-18 | $2.45M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.47M 10-Q · filed 2024-05-07 | $2.60M derived: sum of 2 quarters · filed 2025-02-18 | $2.22M derived: sum of 3 quarters · filed 2025-02-18 | $1.40M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $758.00K derived: sum of 2 quarters · filed 2025-02-18 | -$67.00K derived: sum of 3 quarters · filed 2025-02-18 | -$2.16M 10-K · filed 2025-02-18 |
| 2022-09-30 | -$373.00K 10-Q · filed 2023-11-07 | -$1.20M derived: sum of 2 quarters · filed 2023-11-07 | -$3.29M 10-Q · filed 2023-11-07 | -$3.95M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | -$825.00K 10-Q · filed 2023-08-10 | -$2.92M 10-Q · filed 2023-08-10 | -$3.58M derived: sum of 3 quarters · filed 2024-02-20 | -$3.63M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | -$2.09M 10-Q · filed 2023-05-09 | -$2.75M derived: sum of 2 quarters · filed 2024-02-20 | -$2.80M derived: sum of 3 quarters · filed 2024-02-20 | -$2.80M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$708.00K derived: sum of 2 quarters · filed 2024-02-20 | -$711.00K derived: sum of 3 quarters · filed 2024-02-20 | -$719.00K 10-K · filed 2024-02-20 |
| 2021-09-30 | -$46.00K 10-Q · filed 2022-11-08 | -$49.00K derived: sum of 2 quarters · filed 2022-11-08 | -$57.00K 10-Q · filed 2022-11-08 | -$84.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | -$3.00K 10-Q · filed 2022-08-15 | -$11.00K 10-Q · filed 2022-08-15 | -$38.00K derived: sum of 3 quarters · filed 2023-03-07 | -$60.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-10 | -$35.00K derived: sum of 2 quarters · filed 2023-03-07 | -$57.00K derived: sum of 3 quarters · filed 2023-03-07 | $0.00 derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$50.00K derived: sum of 2 quarters · filed 2023-03-07 | $7.00K derived: sum of 3 quarters · filed 2023-03-07 | -$58.00K 10-K · filed 2023-03-07 |
| 2020-09-30 | -$22.00K 10-Q · filed 2021-11-15 | $35.00K derived: sum of 2 quarters · filed 2021-11-15 | -$30.00K 10-Q · filed 2021-11-15 | -$43.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-06-30 | $57.00K 10-Q · filed 2021-08-10 | -$8.00K 10-Q · filed 2021-08-10 | -$21.00K derived: sum of 3 quarters · filed 2022-03-18 | $20.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-03-31 | -$65.00K 10-Q · filed 2021-05-10 | -$78.00K derived: sum of 2 quarters · filed 2022-03-18 | -$37.00K derived: sum of 3 quarters · filed 2022-03-18 | -$8.00K derived: sum of 4 quarters · filed 2022-03-18 |
| 2019-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $28.00K derived: sum of 2 quarters · filed 2022-03-18 | $57.00K derived: sum of 3 quarters · filed 2022-03-18 | $96.00K 10-K · filed 2022-03-18 |
| 2019-09-30 | $41.00K 10-Q · filed 2020-11-12 | $70.00K derived: sum of 2 quarters · filed 2020-11-12 | $109.00K 10-Q · filed 2020-11-12 | $95.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-06-30 | $29.00K 10-Q · filed 2020-08-12 | $68.00K 10-Q · filed 2020-08-12 | $54.00K derived: sum of 3 quarters · filed 2021-03-23 | $70.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-03-31 | $39.00K 10-Q · filed 2020-05-12 | $25.00K derived: sum of 2 quarters · filed 2021-03-23 | $41.00K derived: sum of 3 quarters · filed 2021-03-23 | $35.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2018-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $2.00K derived: sum of 2 quarters · filed 2021-03-23 | -$4.00K derived: sum of 3 quarters · filed 2021-03-23 | -$30.00K 10-K · filed 2021-03-23 |
| 2018-09-30 | $16.00K 10-Q · filed 2019-11-13 | $10.00K derived: sum of 2 quarters · filed 2019-11-13 | -$16.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$6.00K 10-Q · filed 2019-08-12 | -$32.00K 10-Q · filed 2019-08-12 | ||
| 2017-12-31 | -$1.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |